Archive Newsletter

1. 11.14.25 -- Overcoming Roadblocks To Advanced Therapy Manufacture 11/14/2025

   11/14/25 Cell & Gene Newsletter

2. 11.14.25 -- Global Implications Of Zero Tariffs On Indian Pharma Exports To China 11/14/2025
   11/14/25 Cell & Gene Newsletter
3. 11.13.25 -- Controlling Critical Quality Attributes In RNA Manufacturing 11/13/2025

   11/13/25 Cell & Gene Newsletter

4. 11.13.25 -- Designing Early Manufacturing For Long-Term Success In CGT 11/13/2025
   11/13/25 Cell & Gene Newsletter
5. 11.12.25 -- Take Strides Not Steps With Your Cell & Gene Therapy Manufacturing Process 11/12/2025

   11/12/25 Cell & Gene Newsletter

6. 11.12.25 -- How NK Cell Therapies Are Poised For Breakthroughs In Cancer 11/12/2025
   11/12/25 Cell & Gene Newsletter
7. 11.11.25 -- The Keys To IRB And IBC Compliance For Gene Therapy Trials For Neurological Disorders 11/11/2025

   11/11/25 Cell & Gene Newsletter

8. 11.11.25 -- STREAM Edition: Advancing Allogeneic Cell Therapy For SCI And Blindness 11/11/2025

   11/11/25 Cell & Gene Newsletter

9. 11.11.25 -- What You Should Know About USP's Bioassay Updates 11/11/2025
   11/11/25 Cell & Gene Newsletter
10. 11.10.25 -- Utilizing Adherent Cell Lines For Scalable Manufactuing Of Biologics, Vaccines, And Cell & Gene Therapies 11/10/2025

    11/10/25 Cell & Gene Newsletter